Rectal Adenoma
7
1
1
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.3%
1 terminated out of 7 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System
Advanced Endoscopic Resections for Rectal Neoplasms
Use of a Novel Camera to Check the Bowel After Polyp or Tumour Removal
Transanal Resection of Rectal Lesions With the ColubrisMX ELS System
Predicting Rectal Adenoma With Canceration and Investigating Mechanism Based on Multimodal MRI and Biochemical Model
Efficiency of Two Dimensional High Definition vs Three Dimensional Endoscopic Systems in Transanal Endoscopic Surgery
Trial on Use of Coloshield in Transanal and Anal Surgery